Non-profit developer Aeras is teaming up with the China National Biotec Group (CNBG) to jointly develop new tuberculosis vaccines. Financial details of the deal were not disclosed. CNBG and...
TapImmune has signed a deal with non-profit development group Aeras for preclinical work on a tuberculous vaccine. TapImmune's technology is designed to make vaccines more effective by boosting
In an effort to combat tuberculosis, Aeras and the Oxford-Emergent Tuberculosis Consortium have announced the start of a Phase IIb trial of the MVA85A vaccine. The 1,400-person proof-of-concept study
After years of inattention, health officials are preparing an ambitious set of field trials for the first new tuberculosis vaccine since 1920. And health officials in Uganda, where the vaccine will
The nonprofit Aeras Global TB Vaccine Foundation in Rockville, MD has opened the doors to a new manufacturing facility that has the capacity to satisfy the worldwide demand for TB vaccine. The